Search results for "ALZHEIMER"

showing 10 items of 706 documents

Gruppentherapeutische Frühintervention für Patienten im Frühstadium der Alzheimererkrankung und deren Angehörige - Eine Pilotstudie

2008

Subject Pilot study on an early-interventional group therapy for patients with incipient Alzheimer disease and their relatives. The present study investigates whether scientific progress in terms of earlier time of diagnostic certainty can be used for psychoeducation, maintenance of positive activities and prevention of comorbid depressive episodes. Methods 12 patients (66.8 +/- 5.8 years, MMSE 24.0 +/- 4.0) together with 12 relatives have been treated with a bi-weekly group therapy program. Results For the patients treatment resulted in reduced anxiety, anergia and withdrawal, for their relatives reduced sleep disturbances, irascibility, and aggressiveness have been found. Only one of the …

medicine.medical_specialtyPediatricsbusiness.industrymedicine.medical_treatmentmedicine.diseaseComorbidityGroup psychotherapyPsychiatry and Mental healthClinical PsychologyQuality of lifemedicinePsychoeducationAnxietymedicine.symptomAlzheimer's diseasePsychiatrybusinessProspective cohort studyPsychosocialApplied PsychologyPPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie
researchProduct

Restoration of cerebral and systemic microvascular architecture in APP/PS1 transgenic mice following treatment with Liraglutide™.

2015

OBJECTIVE: Cerebral microvascular impairments occurring in AD may reduce Aβ peptide clearance and impact upon circulatory ultrastructure and function. We hypothesized that microvascular pathologies occur in organs responsible for systemic Aβ peptide clearance in a model of AD and that Liraglutide (Victoza(®)) improves vessel architecture. METHODS: Seven-month-old APP/PS1 and age-matched wild-type mice received once-daily intraperitoneal injections of either Liraglutide or saline (n = 4 per group) for eight weeks. Casts of cerebral, splenic, hepatic, and renal microanatomy were analyzed using SEM. RESULTS: Casts from wild-type mice showed regularly spaced microvasculature with smooth lumenal…

medicine.medical_specialtyPhysiologySpleenMice TransgenicKidneyMicrocirculationAmyloid beta-Protein PrecursorMiceAlzheimer DiseaseGlucagon-Like Peptide 1Physiology (medical)Internal medicinemedicinePresenilin-1AnimalsHumansHypoglycemic AgentsMolecular BiologyKidneybusiness.industryLiraglutideMicrocirculationBrainLiraglutideGlucagon-like peptide-1Extravasationmedicine.anatomical_structureEndocrinologyCerebrovascular CirculationCirculatory systemMicrovesselsSystemic administrationCardiology and Cardiovascular MedicinebusinessSpleenmedicine.drugMicrocirculation (New York, N.Y. : 1994)
researchProduct

A systematic review of neuropsychiatric symptoms in mild cognitive impairment.

2009

Mild cognitive impairment (MCI) is a clinical concept proposed as an intermediate state between normal aging and dementia. This condition has multiple heterogeneous sources, including clinical presentation, etiology, and prognosis. Recently, the prevalence and associated features of neuropsychiatric symptoms (NPS) in MCI have been described. We systematically searched the PubMed database (last accessed on August 31, 2008) for articles on NPS in MCI. Included articles used strict selection criteria, and outcome variables were extracted in duplicate; of the 27 articles included, 14 (52%) used prospective cohorts. The global prevalence of NPS in MCI ranged from 35% to 85%. The most common beha…

medicine.medical_specialtyPopulationDiseaseNeuropsychological TestsIrritabilitybehavioral disciplines and activitiesAlzheimer DiseaseRisk FactorsInternal medicinemental disordersmedicineDementiaAlzheimer’s disease behavior dementia depression incidence mild cognitive impairment neuropsychiatric symptoms predictors prevalence risk factorsHumansProspective cohort studyeducationDepression (differential diagnoses)education.field_of_studyClinical Trials as TopicGeneral NeuroscienceMental DisordersGeneral Medicinemedicine.diseasePsychiatry and Mental healthClinical PsychologyEtiologyAnxietySettore MED/26 - NeurologiaGeriatrics and Gerontologymedicine.symptomPsychologyCognition DisordersClinical psychologyJournal of Alzheimer's disease : JAD
researchProduct

The Association between Tooth Loss and Alzheimer's Disease: a Systematic Review with Meta-Analysis of Case Control Studies.

2019

Alzheimer’s disease is classified as a neurodegenerative condition, a heterogeneous group of illnesses characterized by the slow and progressive loss of one or more functions of the nervous system. Its incidence tends to increase gradually from 65 years of age, up to a prevalence of 4% at age 75. The loss of dental elements is more prevalent in this population and might negatively affect the masticatory capacity, quality of life, and pathogenesis of Alzheimer’s disease. This study investigated problems related to oral health and the loss of dental elements in elderly patients suffering from Alzheimer’s and considered whether local inflammatory processes could affect the et…

medicine.medical_specialtyPopulationDiseaseReview03 medical and health sciences0302 clinical medicineInternal medicinetooth lossTooth lossmedicineDementiaeducationGeneral DentistryperiodontitisPeriodontitiseducation.field_of_studyEdentulismbusiness.industryHazard ratioCase-control study030206 dentistrymedicine.diseaselcsh:RK1-715stomatognathic diseaseslcsh:Dentistrymedicine.symptombusinessAlzheimer’s disease030217 neurology & neurosurgerydementiaDentistry journal
researchProduct

Use of a Virtual Environment to Engage Motor and Postural Abilities in Elderly Subjects With and Without Mild Cognitive Impairment (MAAMI Project)

2016

Objectives: In the context of rehabilitation, the use of new technology such as Virtual Reality Technology (VRT) offers multiple possibilities to modulate the functional stimulation of subjects according to needs. Material and methods: In this study, the validity and reliability of our VRT system were investigated in fifteen healthy aged adults (HAA) and seven aged subjects with mild cognitive impairment (MCI). One implicit session was designed through two virtual environments (VEs) in order to induce the adapted activities associated with balance and postural control. In comparison, the same activities were achieved in explicit sessions with a physiotherapist. This cross-over study made us…

medicine.medical_specialtySynthèse d'image et réalité virtuelle [Informatique]media_common.quotation_subjectmedicine.medical_treatment[INFO.INFO-GR] Computer Science [cs]/Graphics [cs.GR]Biomedical EngineeringBiophysicsValidityContext (language use)Virtual realityVirtual reality050105 experimental psychologySession (web analytics)rehabilitationDevelopmental psychology03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitation[ INFO.INFO-HC ] Computer Science [cs]/Human-Computer Interaction [cs.HC]medicine0501 psychology and cognitive sciences[INFO.INFO-HC]Computer Science [cs]/Human-Computer Interaction [cs.HC]media_commonBalance (ability)RehabilitationRehabilitation05 social sciences[ INFO.INFO-GR ] Computer Science [cs]/Graphics [cs.GR][INFO.INFO-GR]Computer Science [cs]/Graphics [cs.GR]Interface homme-machine [Informatique]FeelingAlzheimervirtual reality[INFO.INFO-HC] Computer Science [cs]/Human-Computer Interaction [cs.HC]Motor learningPsychology030217 neurology & neurosurgeryIRBM
researchProduct

The lyon clinical olfactory test: validation and measurement of hyposmia and anosmia in healthy and diseased populations.

2011

 ; International audience; The LCOT is a self-administered test designed to assess olfactory deficits. Altogether, 525 subjects contributed to the validation. Elderly participants were well represented in this sample. In a validation study (study 1), 407 healthy and 17 anosmic volunteers between 15 and 91 years of age underwent threshold, supraliminal detection, and identification testing. Cutoff values for normosmia and hyposmia were calculated and applied in a second study in a group of patients with smell complaints and in a group of Alzheimer patients with age-matched controls. Incidence of smell deficit was estimated at 5.6% in the healthy population of study 1, and at 16% in the elder…

medicine.medical_specialtyValidation studyArticle SubjectOlfactory disorderAnosmialcsh:SurgeryMédecine humaine et pathologieOlfactionTest validityAudiologyBioinformaticsaging;development;olfaction;olfactory disorder;Alzheimer's disease;cognitive impairment03 medical and health sciences0302 clinical medicineHyposmiamedicineFood and Nutrition[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs030223 otorhinolaryngologyolfactory disorderdevelopmentcognitive impairmentbusiness.industryIncidence (epidemiology)Healthy populationaging[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologielcsh:RD1-811Alzheimer's diseaselcsh:Otorhinolaryngologylcsh:RF1-547[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansAlimentation et NutritionNeurosciences (Sciences cognitives)Human health and pathology[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiemedicine.symptombusiness030217 neurology & neurosurgeryResearch ArticleNeuroscienceolfaction
researchProduct

Weight loss in Alzheimer’s disease, vascular dementia and dementia with Lewy bodies: Impact on mortality and hospitalization by dementia subtype

2021

Objectives Loss of weight is associated with cognitive decline as well as several adverse outcomes in dementia. The aim of this study was to assess whether weight loss is associated with mortality and hospitalization in dementia subtypes. Methods A cohort of 11,607 patients with dementia in Alzheimer's disease (AD), vascular dementia (VD), or dementia with Lewy bodies (DLB) was assembled from a large dementia care health records database in Southeast London. A natural language processing algorithm was developed to established whether loss of weight was recorded around the time of dementia diagnosis. Cox proportional hazard models were applied to examine the associations of reported weight l…

medicine.medical_specialtyWeight lossInternal medicinemental disordersmedicineDementiaCognitive declineVascular dementiaImpact on mortality and hospitalization by dementia subtype.- International journal of geriatric psychiatry 2021 [Soysal P. Tan S. G. Rogowska M. Jawad S. Smith L. Veronese N. Tsiptsios D. Tsamakis K. Stewart R. Mueller C. -Weight loss in Alzheimer-s disease vascular dementia and dementia with Lewy bodies]Dementia with Lewy bodiesbusiness.industryAlzheimer's disease dementia hospitalization Lewy bodies mortality weight lossHazard ratioAlzheimer's diseasemedicine.diseasemortalityConfidence intervalPsychiatry and Mental healthCohortGeriatrics and Gerontologymedicine.symptomweight lossbusinessLewy bodiesdementiahospitalization
researchProduct

Selected Age-Related Disorders

2013

Aged human individuals are frequently affected by various age-related impairments and disorders at once (multimorbidity) making it difficult to investigate and understand the link between aging as key risk factor and single syndromes. In some chapters of this book links have been identified between molecular mechanisms of aging and the pathogenesis of human disorders in the elderly. Here, the focus is put on Alzheimers disease (AD) and cancer. While cancer in many cases can successfully be treated and sometimes even cured by pharmacology and/or surgery, AD is still an incurable deadly disease. Like almost no other disorder the onset of AD is strictly associated with higher age and experienc…

medicine.medical_specialtybusiness.industryCancerContext (language use)Aging societyDiseasemedicine.diseaseAge relatedmedicineRisk factorAlzheimer's diseasePsychiatrybusinessBrain aging
researchProduct

Methodological matters on an Alzheimer's dementia trial: is a double-blind randomized controlled study design sufficient to draw strong conclusions o…

2007

medicine.medical_specialtybusiness.industryGinkgo bilobamedicine.diseaselaw.inventionDouble blindNeurologyRandomized controlled trialDouble-Blind MethodPiperidineslawAlzheimer DiseaseIndansmedicineDementiaHumansAlzheimer s dementiaDementiaDonepezilNeurology (clinical)Cholinesterase InhibitorsPsychiatrybusinessRandomized Controlled Trials as TopicEuropean journal of neurology
researchProduct

Vasomotor reactivity in dementia of alzheimer type

1994

The objective of this study was to examine the cerebral blood flow and the vasomotor function of CO2-responsive intracerebral vessels in Alzheimer's disease. Patients met DSM-III-R criteria for dementia of Alzheimer type and had neither symptoms nor signs of cardiovascular or cerebrovascular disease. Blood flow velocities in both middle cerebral arteries (MCA) were recorded using transcranial Doppler sonography during hypercapnia, normocapnia and hypocapnia. Several psychometric tests were performed. Patients' age, disease duration and severity of dementia did not correlate with vasomotor reactivity. Exploratory analysis revealed that mean flow velocities under hypercapnia correlated with s…

medicine.medical_specialtybusiness.industryHemodynamicsmedicine.diseaseSurgeryCentral nervous system diseasePsychiatry and Mental healthHypocapniaCerebral blood flowInternal medicinemedicine.arteryMiddle cerebral arterymedicineCardiologyDementiaGeriatrics and Gerontologymedicine.symptomAlzheimer's diseasebusinessHypercapniaInternational Journal of Geriatric Psychiatry
researchProduct